Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Strongest evidence backs two tools for evaluating older people with cancer Next Article
ADT add-ons helpful in metastatic prostate cancer »
« Strongest evidence backs two tools for evaluating older people with cancer Next Article
ADT add-ons helpful in metastatic prostate cancer »
Related Articles
November 19, 2021
Adjuvant atezolizumab lowers relapse rate in resected NSCLC
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy